Bill Text: TX HB317 | 2019-2020 | 86th Legislature | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Relating to the use of clinical decision support software and laboratory benefits management programs in connection with the provision of clinical laboratory services to certain managed care plan enrollees.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2019-04-24 - Committee report sent to Calendars [HB317 Detail]
Download: Texas-2019-HB317-Introduced.html
Bill Title: Relating to the use of clinical decision support software and laboratory benefits management programs in connection with the provision of clinical laboratory services to certain managed care plan enrollees.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2019-04-24 - Committee report sent to Calendars [HB317 Detail]
Download: Texas-2019-HB317-Introduced.html
86R616 SMT-F | ||
By: Raymond | H.B. No. 317 |
|
||
|
||
relating to the use of clinical decision support software and | ||
laboratory benefits management programs by physicians and health | ||
care providers in connection with provision of clinical laboratory | ||
services to certain managed care plan enrollees. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Chapter 1451, Insurance Code, is amended by | ||
adding Subchapter L to read as follows: | ||
SUBCHAPTER L. CLINICAL LABORATORIES | ||
Sec. 1451.551. DEFINITIONS. In this subchapter: | ||
(1) "Clinical decision support software" means | ||
computer software that compares patient characteristics to a | ||
database of clinical knowledge to produce patient-specific | ||
assessments or recommendations to assist a physician or health care | ||
provider in making clinical decisions. | ||
(2) "Clinical laboratory service" means the | ||
examination of a specimen taken from a human body ordered by a | ||
physician or health care provider for use in the diagnosis, | ||
prevention, or treatment of a disease or the identification or | ||
assessment of a medical or physical condition. | ||
(3) "Enrollee" means an individual enrolled in a | ||
managed care plan. | ||
(4) "Laboratory benefits management program" means a | ||
managed care plan issuer protocol or program administered by the | ||
managed care plan issuer or another entity under contract with the | ||
managed care plan issuer that dictates, directs, or limits decision | ||
making of a physician or health care provider who is authorized to | ||
order clinical laboratory services. | ||
(5) "Managed care plan" means a health plan provided | ||
by a health maintenance organization under Chapter 843 or a | ||
preferred provider or exclusive provider plan provided by an | ||
insurer under Chapter 1301. | ||
(6) "Managed care plan issuer" means a health | ||
maintenance organization or an insurer that provides a managed care | ||
plan. | ||
Sec. 1451.552. CERTAIN REQUIREMENTS FOR USE OF CLINICAL | ||
LABORATORIES AND LABORATORY SERVICES PROHIBITED. (a) A managed | ||
care plan issuer may not by contract or otherwise require the use of | ||
clinical decision support software or a laboratory benefits | ||
management program by an enrollee's physician or health care | ||
provider before, at the time, or after the physician or health care | ||
provider orders a clinical laboratory service for the enrollee. | ||
(b) A managed care plan issuer may not by contract or | ||
otherwise direct or limit an enrollee's physician or health care | ||
provider in the physician's or provider's clinical decision making | ||
relating to the use of a clinical laboratory service or the referral | ||
of a patient specimen to a clinical laboratory. | ||
(c) A managed care plan issuer may not by contract or | ||
otherwise require, steer, encourage, or otherwise direct an | ||
enrollee's physician or health care provider to refer a patient | ||
specimen to a particular clinical laboratory in the managed care | ||
plan's provider network designated by the managed care plan issuer | ||
other than the clinical laboratory in the network selected by the | ||
physician or health care provider. | ||
(d) A managed care plan issuer may not by contract or | ||
otherwise limit or deny payment of a claim for a clinical laboratory | ||
service based on whether the ordering physician or health care | ||
provider uses or fails to use clinical decision support software or | ||
a laboratory benefits management program. | ||
(e) Nothing in this section prohibits a managed care plan | ||
issuer from requiring a prior authorization for clinical laboratory | ||
services provided that the managed care plan issuer imposes the | ||
requirement uniformly to all laboratories providing clinical | ||
laboratory services in the managed care plan's provider network. | ||
Sec. 1451.553. APPLICABILITY OF SUBCHAPTER TO ENTITIES | ||
CONTRACTING WITH MANAGED CARE PLAN ISSUER. This subchapter applies | ||
to a person with whom a managed care plan issuer contracts to: | ||
(1) manage or administer laboratory benefits; | ||
(2) process or pay claims; | ||
(3) obtain the services of physicians or other | ||
providers to provide health care services to enrollees; or | ||
(4) issue verifications or preauthorizations. | ||
SECTION 2. Subchapter L, Chapter 1451, Insurance Code, as | ||
added by this Act, applies only to a contract between a managed care | ||
plan issuer and a physician or provider that is entered into or | ||
renewed on or after the effective date of this Act. A contract | ||
entered into or renewed before the effective date of this Act is | ||
governed by the law as it existed immediately before the effective | ||
date of this Act, and that law is continued in effect for that | ||
purpose. | ||
SECTION 3. This Act takes effect September 1, 2019. |